skip to Main Content

Funding Injection For New Antibiotics: The CARB-X Transatlantic Partnership

A partnership of government agencies and organisations in the United States and United Kingdom have announced an investment of up to US$48 million into the development of new antibiotics and products to fight antibiotic resistant bacteria, with the aim of having two new antibiotics in human trials in the next five years.
Go to Source
Author: Kim Treanor

Back To Top